Calton & Associates’s Nuveen Dow 30SM Dynamic Overwrite Fund DIAX Stock Holding History
Bought
Maintained
Sold
Other funds holding DIAX
RJFSA
AAM
OA
RJA
Calton & Associates's DIAX Position: Q3 2019 in Review
Calton & Associates sold out of Nuveen Dow 30SM Dynamic Overwrite Fund (DIAX) in Q3 2019, closing a stake of 10,971 shares — an estimated $193K sold.
Calton & Associates first reported a position in DIAX in Q4 2017 and held it in 4 quarters. The position peaked at $258K in Q2 2018. 74 funds tracked by Wall St. Rank hold DIAX as of Q3 2019.
- Calton & Associates reported no remaining Nuveen Dow 30SM Dynamic Overwrite Fund position as of Q3 2019 after selling out during the quarter.
- Calton & Associates sold 10,971 Nuveen Dow 30SM Dynamic Overwrite Fund shares in Q3 2019, an estimated $193K.
- Calton & Associates first reported a position in Nuveen Dow 30SM Dynamic Overwrite Fund in Q4 2017 and held it in 4 quarters.
- Calton & Associates's Nuveen Dow 30SM Dynamic Overwrite Fund position peaked at $258K in Q2 2018.
- 74 funds tracked by Wall St. Rank held Nuveen Dow 30SM Dynamic Overwrite Fund as of Q3 2019.
Based on Calton & Associates's 13F filing for Q3 2019, filed 7 Nov 2019.